Sulzer: Counterfeiters and Patent Infringers at the IDS 2017 – Sulzer Mixpac Continues to Enforce Its Rights
Sulzer Mixpac Ltd (SULZER) operates globally in the field of static mixing tips, cartridges and dispensing devices for the dental sector. In recent times, substantially identical copies of the static mixing tips for two-component cartridges and syringes have increasingly been discovered. These copies by other manufacturers are not subject to SULZER's strict quality controls and are therefore not covered by its warranty. In the interests of its clients, SULZER will continue to take legal steps against all such copies.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170726005664/en/
Patent infringement actions were filed against three Korean suppliers of mixing tips who were offering them at the IDS 2017. (Photo credit: Sulzer Mixpac, reproduction free of charge)
With its ruling back in 2010, the Cologne District Court decided many years ago that the mixing tips forming the basis of our complaint represent unfair copies of the mixing tips of Sulzer Mixpac Ltd. and result in an avoidable deception with respect to the commercial origin (Court ref.: 33 O 306/09). This decision was also then confirmed in the second instance by the Cologne Higher Regional Court with its 2011 ruling (Court ref.: 6 U 189/10).
SULZER has continued to successfully enforce these rights over the years in many dozens of court actions against, or out-of-court settlements with, slavish imitators of its mixing tips as well as to successfully enforce its patent, trademark or other IP rights against certain infringing colored mixing tips in many countries, such as Germany, Japan, the US and the UK.
Despite these measures, in the years 2016/2017 further unfair slavish copies of the mixing tips and/or patent-infringing mixing tips were discovered and action was taken, for example, in Germany. Shortly before the IDS 2017, several distributors of mixing tips infringing EP0885651 in Germany were stopped by accepted court decisions or out-of-court settlements. In addition, patent infringement actions were filed at the Dusseldorf District Court against three Korean suppliers of mixing tips infringing EP0885651 who were offering them at the IDS 2017, B&E Korea Co., Han Dae Chemical, and HDI Inc. All three infringers have now accepted the preliminary injunctions as a final binding decision. In addition, the Korean manufacturer of these patent-infringing mixing tips, Seil Global, has agreed to respect SULZER’s rights worldwide for all members of the patent family for their remaining lifetimes.
In addition, a total of eleven preliminary injunctions due to unfair competition were obtained from the Cologne District Court against various providers of slavish copies of SULZER’s mixing tips during the IDS 2017 by which inter alia the offering, advertising and marketing of these copied mixing tips for the dental sector were prohibited. Furthermore a preliminary injunction from the Dusseldorf District Court was served at the IDS 2017 on an exhibitor offering dynamic mixers infringing SULZER’s European patent, EP1943012.
We recommend that you will continue to take great care to ensure that you actually do receive the original mixing tips from Sulzer Mixpac. We can only guarantee the proven high MIXPACTM quality for original MIXPAC dental products made exclusively by SULZER at its automated clean room factory in Switzerland where strict quality control, close tolerances and rigid cleanliness standards produce mixing tips of the highest quality, safety and reliability.
Sulzer’s innovative T-Mixer™ that offers superior mixing performance with less waste is becoming the preferred choice for mixing tips.
MIXPAC mixing tips are the industry leader for 2-component static mixing solutions for dental applications. The mixing tips have a Dome shape and CANDY COLORS™ (yellow, teal, blue, pink, purple and brown) registered as trademarks in several countries used with a materials cartridge. The MIXPAC system is also protected by European, U.S. and other national patents. MIXPAC dental products are made exclusively by Sulzer at its automated clean room factory in Switzerland where strict quality control, close tolerances and rigid cleanliness standards produce mixing tips of the highest quality, safety and reliability.
Sulzer is committed to protecting its products. Genuine MIXPAC tips can be identified by the MIXPAC™ name stamped on the retaining ring and the CANDY COLOR Quality Seal.
ABOUT SULZER MIXPAC
With more than 850 employees, Sulzer Mixpac Ltd. is a world leading manufacturer and supplier of cartridge-based metering, mixing and dispensing systems and disposable mixers for reactive multi-component materials.
As part of the Sulzer group, Sulzer Mixpac Ltd. can draw on a strong international network. The head office is located in Switzerland. For optimal service to its customers, subsidiaries are located in the U.S., UK and China.
MIXPAC™ - is a registered trademark of Sulzer Mixpac Ltd., Switzerland.
T-MIXERTM - is a registered trademark of Sulzer Mixpac Ltd., Switzerland.
CANDY COLORSTM – is a registered trademark of Sulzer Mixpac Ltd., Switzerland.
Sulzer Mixpac Ltd
Head of Marketing
Tel: +41 (0)81 772 2164
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet’s Disease with Oral Ulcers17.2.2018 21:00 | Pressemelding
Celgene Corporation (NASDAQ:CELG) today announced that data from the phase III RELIEF™ clinical trial of OTEZLA® (apremilast) in patients with active Behçet’s Disease with oral ulcers were presented in a late-breaking oral presentation at the 2018 American Academy of Dermatology (AAD) Annual Meeting. The results showed statistically significant reductions in oral ulcers with apremilast 30 mg twice daily (BID) versus placebo through week 12. OTEZLA (apremilast) is Celgene’s oral selective inhibitor of phosphodiesterase 4 (PDE4). Behçet’s Disease is a rare, chronic, multi-system inflammatory syndrome. Oral ulcers, the most common manifestation of Behçet’s Disease, can be disabling and have a substantial effect on quality of life. This study primarily evaluated the effect of apremilast on recurring oral ulcers in patients with active Behçet’s Disease who were previously treated with at least one topical or systemic medication. “Reducing oral ulcers, which are painful and can negatively im
CT-P13 (biosimilar infliximab) is comparable to reference infliximab and adalimumab in highly anticipated real-world study17.2.2018 08:00 | Pressemelding
Twelve-month data from the Personalised Anti-TNF therapy in Crohn’s disease Study (PANTS) was presented at the 13th Congress of the European Crohn’s and Colitis Organisation (ECCO). The results indicate that the clinical effectiveness, safety and immunogenicity of Celltrion Healthcare’s CT-P13 (biosimilar infliximab) in patients with Crohn’s disease (CD) is comparable to those treated with reference infliximab as well as those treated with adalimumab.1 The UK-wide, three-year prospective observational study investigated primary non-response (PNR), loss of response (LOR) and adverse drug reactions (ADR) to infliximab (reference infliximab and CT-P13) and adalimumab in 1610 CD patients. The data show comparable efficacy between CT-P13, reference infliximab and adalimumab in relation to PNR, LOR and ADR rates. In addition, at week 54, the remission rate was 39.7%, 39.0% and 32.7% for reference infliximab, CT-P13 and adalimumab treated patients, respectively.1 The PANTS study investigates
Avanti Communications HYLAS 4 Satellite Arrives in French Guiana16.2.2018 18:26 | Pressemelding
Avanti Communications Group plc (“Avanti”), a leading provider of satellite data communications services in Europe, the Middle East and Africa (“EMEA”), announces its HYLAS 4 satellite has arrived safely in French Guiana ahead of its March 2018 launch. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005586/en/ Avanti Communications HYLAS 4 Satellite Arrives in French Guiana (Photo: Business Wire) The spacecraft, built by Orbital ATK was packed and shipped at their Satellite Manufacturing Facility in Dulles, Virginia, United States and flown to French Guiana, where it was unloaded and will be taken to the Arianespace launch facilities in Kourou. HYLAS 4 uses the latest High Throughput Satellite technology, doubling Avanti's Ka-band capacity across EMEA. The latest addition to Avanti's HYLAS fleet will provide: Backhaul services for mobile network operators Wholesale broadband for ISPs Connectivity for governments (civil a
General Cable Corporation Stockholders Approve Acquisition By Prysmian Group16.2.2018 17:05 | Pressemelding
General Cable Corporation (NYSE: BGC) today announced the voting results from the Company’s special meeting of stockholders held this morning. Stockholders of General Cable approved the Company’s previously announced acquisition by Prysmian Group (BIT: PRY) for $30.00 per share in cash. A total of 38,140,754 shares, representing approximately 75.34% of the total number of shares of common stock outstanding and approximately 99% of the total votes cast, were voted in favor of the merger. Subject to regulatory approvals and other customary closing conditions, the transaction is expected to close by the third quarter of 2018. About General Cable General Cable (NYSE:BGC), with headquarters in Highland Heights, Kentucky, is a global leader in the development, design, manufacture, marketing and distribution of aluminum, copper and fiber optic wire and cable products for the energy, communications, automotive, industrial, construction and specialty segments. General Cable is one of the larges
Systemic Sclerosis World Congress:Inspirational Patient Stories Reveal the Challenging Realities of Living with Devastating Rare Disease16.2.2018 09:03 | Pressemelding
Boehringer Ingelheim today unveils a new phase of 'More Than Scleroderma: The Inside Story', and launches the new patient website www.morethanscleroderma.com. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005188/en/ Anna, 36, living with scleroderma (Photo: Business Wire) The global initiative highlights the importance of understanding the ‘inside story’ of each individual living with scleroderma, also known as systemic sclerosis. To coincide with the Systemic Sclerosis World Congress in Bordeaux, 15-17 February 2018, new and truly inspiring patient stories are revealed, reflecting the real-life, diverse and very moving journeys of people living with scleroderma across the world. The campaign will also be launched in the U.S. The new website www.morethanscleroderma.com features a powerful collection of photographs and video stories of people living with scleroderma across the world, revealing the life-changing impact o
Philip Morris International Recognized as a Global Top Employer for the Second Year in a Row16.2.2018 08:00 | Pressemelding
Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today is recognized for the second year in a row as a Global Top Employer. This year’s certification from the Top Employer Institute is awarded to PMI teams in 44 countries, a testament to the company’s consistency and excellence in offering an enriching and dynamic work environment, and exceptional development opportunities for employees across the globe. PMI has been recognized by the Top Employer Institute for six consecutive years. This year, PMI was awarded with five regional certifications in Europe, the Middle East, Africa and, for the first time, in North America and Latin America. Additionally, Indonesia was the first PMI affiliate to be certified in Asia. “It is a proud moment for all of us at PMI,” said Charles Bendotti, PMI Senior Vice President, People and Culture. “Our success as a company relies on the men and women who come to work every day with a passion to achieve, and a willingness to learn, grow, and